AI-driven prediction of progression to oral squamous cell carcinoma using a multiresolution pathology model
Potentially malignant oral lesions are visible mucosal changes with risk of progressing to squamous cell carcinoma. These lesions are currently graded as no, mild, moderate, or severe dysplasia per WHO guidelines. While widely used, this system is subjective, imprecise, and limited in distinguishing low-risk from high-risk lesions. To address this, we developed a multiresolution deep learning model using digital pathology to predict malignant transformation. Trained on 221 digitized whole-slide images (111 progressors, 110 non-progressors), our vision transformer (ViT) model outperformed traditional CNN-based models, achieving 80.0% accuracy, an F1-score of 77.3%, and an AUROC of 0.798. Importantly, AI-predicted progression aligned with histopathologic features such as abnormal keratinization, increased apoptosis, and nuclear changes characteristic of malignancy. While further validation in larger, prospective cohorts is needed, our model demonstrates promise as an adjunctive tool for identifying high-risk lesions, potentially improving risk stratification, and guiding treatment decisions.
Authors
- Alivia M. Shasteen
- Elizabeth Ann Bilodeau (ORCID: https://orcid.org/0000-0003-1288-3923)
- Raja R. Seethala (ORCID: https://orcid.org/0000-0003-3617-075X)
- D.J. Foran
- Yingci Liu-Swetz
- Sead Niksic
Institutions
- Rutgers, The State University of New Jersey (US)
- Lincoln Memorial University (US)
- University of Pittsburgh (US)
- Rutgers Sexual and Reproductive Health and Rights (NL)
- Decatur Memorial Hospital (US)
- Atlanta VA Medical Center (US)
Publication Details
- Journal
- npj Digital Medicine
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1038/s41746-025-02014-1
- Citations
- 1
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 2.48
Funders
- National Institutes of Health
- National Center for Advancing Translational Sciences